Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UltraSight, previously known as OnSight Medical, is a private digital health and medical device company developing AI-guided cardiac ultrasound software. Its products are designed to help non-expert healthcare professionals acquire diagnostic-quality cardiac ultrasound images at the point of care across clinics, hospitals, ambulances, and other settings. The company has received U.S. FDA clearance for its AI-powered cardiac ultrasound guidance technology and later expanded clearance for broader ultrasound system compatibility, indicating an early commercial stage. UltraSight also launched PVAD IQ for bedside echocardiographic support in patients on microaxial flow pumps and has built collaborations with health systems, ultrasound OEMs, and academic medical centers to validate and deploy its platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UltraSight.